Skip to main content
Christopher Janson, MD, Neurosurgery, Stratford, NJ

Christopher Janson MD


Physician

Join to view full profile
  • 42 E Laurel RdSte 1800-AStratford, NJ 08084

  • Phone+1 856-566-6843

  • Fax+1 856-566-6419

Dr. Janson is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Minnesota
    University of MinnesotaResidency, Neurology, 2011 - 2014
  • University of Minnesota
    University of MinnesotaResidency, Neurological Surgery, 2006 - 2011
  • M Health Fairview
    M Health FairviewInternship, Transitional Year, 2005 - 2006
  • Yale School of Medicine
    Yale School of MedicineClass of 2001

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2011 - 2029
  • AZ State Medical License
    AZ State Medical License 2025 - 2028
  • IN State Medical License
    IN State Medical License 2025 - 2027
  • MO State Medical License
    MO State Medical License 2006 - 2027
  • MT State Medical License
    MT State Medical License 2025 - 2027
  • NJ State Medical License
    NJ State Medical License 2022 - 2027
  • OH State Medical License
    OH State Medical License 2019 - 2027
  • Neurology
    American Board of Psychiatry and Neurology Neurology
  • Vascular Neurology
    American Board of Psychiatry and Neurology Vascular Neurology
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Breakthrough Gene Therapy Shows Hope for Treating Fatal Childhood Leukodystrophy
    Breakthrough Gene Therapy Shows Hope for Treating Fatal Childhood LeukodystrophySeptember 10th, 2025
  • Myrtelle Announces Positive Preliminary Clinical Data for Its Proprietary Gene Therapy in Canavan Disease
    Myrtelle Announces Positive Preliminary Clinical Data for Its Proprietary Gene Therapy in Canavan DiseaseFebruary 15th, 2022
  • Myrtelle Announces Presentation at the 5th Annual Gene Therapy for Neurological Disorders Summit
    Myrtelle Announces Presentation at the 5th Annual Gene Therapy for Neurological Disorders SummitNovember 8th, 2023

Grant Support

  • Differential clearance of pyroglutamate abeta through arachnoid and meningeal lymphatics in Alzheimer DiseaseROWAN UNIVERSITY SCHOOL/OSTEOPATHIC MED2019–2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: